Business
Aphex BioCleanse Systems Reports 2021 Third Quarter Operational Results
Aphex BioCleanse Systems Reports 2021 Third Quarter Operational Results.
About this update from Sunset Capital Assets, Inc.
[{"type":"text","content":"\n\n\n\nAphex BioCleanse Systems Reports 2021 Third Quarter Operational Results\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAphex BioCleanse Systems Reports 2021 Third Quarter Operational Results\nPR Newswire\nPITTSFORD, N.Y., Nov. 15, 2021\n\n\n\nPITTSFORD, N.Y., Nov. 15, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) (\"Aphex\" or \"the Company\"), a cutting-edge cleaning and disinfection company offering zero-footprint environmental remediation products, and known for its highly acclaimed non-toxic and water-based disinfection product line, Hy-IQ® Water, today announced a filing of its required financial and disclosure reports with the OTC Pink reporting service for the quarter ending September 30, 2021.\n\n \n \n \n \n \n \n\n \nOperational Highlights as of End of Third Quarter 2021\nCompleted strategic changes in the Aphex executive leadership team and composition of its Board of Directors, renewing focus on strategic market development, seeking regulatory approvals and achieving operational success Received notice of issuance of a new patent (US 11,112,397) for Open-Cell Foam Biological Indicator for Bacteria Detection & Removal from Water or Air, and Methods of Use Exhibited at the ASD (Affordable Shopping Destination) Market Week convention where Scott Smith, Aphex's Chief Sustainability Officer and Founder of bioFOAM™, presented a keynote address on environmentally friendly consumer cleaning products\"The third quarter of 2021 was a transitional and pivotal quarter for Aphex, and I can happily share that we effectively used it to re-position the company for further success headed into the remainder of the year and 2022,\" said Tom Fitzgerald, Aphex's Chairman of the Board. \"We are looking to continue on our path toward regulatory approval of the Hy-IQ cleaning solution, propelling our Company into final stages of product commercialization setting a clear path to sustained revenue with some of the largest global players in the space. Beyond that, we remain laser-focused on generating sales and levera...